The Insulin Infusion Pump Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The global market for insulin infusion pumps has seen significant expansion in recent years. It is projected that the market, which was worth $6.33 billion in 2024, will increase to $6.99 billion in 2025. This represents a compound annual growth rate (CAG
The global insulin infusion pump market is forecasted to reach $10.31 billion by 2029, growing at a compound annual growth rate (CAGR) of 10.2%.
Download Your Free Sample of the 2025 Insulin Infusion Pump Market Report and Uncover Key Trends Now!The key drivers in the insulin infusion pump market are:
• Expanding access to telehealth services
• Increasing cases of chronic diseases
• Rising demand for personalized medicine
• Growing awareness amongst physicians and patients
The insulin infusion pump market covered in this report is segmented –
1) By Type: Continuous Subcutaneous Insulin Infusion Pumps, Insulin Delivery Pens, Wearable Insulin Pumps
2) By Technology: Remote Monitoring Systems, Closed Loop Systems, Smart Insulin Pumps
3) By End Use: Hospitals, Home Care Settings, Diabetes Clinics
The key trends in the insulin infusion pump market are:
• The advancement in closed-loop systems is a significant emerging trend.
• There is a rising influence of artificial intelligence (AI) and machine learning in the market.
• Technology developments focused on wireless connectivity are shaping the market.
• The trend towards pump miniaturization and integration with wearable devices is increasing.
Major players in the insulin infusion pump market are:
• Pfizer Inc.
• Roche Holding AG
• Sanofi S.A.
• Medtronic plc
• Eli Lilly and Company
• Becton, Dickinson and Company
• Baxter International Inc.
• Terumo Corporation
• Smiths Group plc
• Moog Inc.
• ICU Medical Inc.
• Insulet Corporation
• MicroPort Scientific Corporation
• Tandem Diabetes Care Inc.
• Ypsomed Holding AG
• B. Braun Melsungen AG
• Beta Bionics Inc.
• SOOIL Development Co. Ltd.
• Fresenius SE & Co. KGaA
• Shinmyung Mediyes Co. Ltd.
North America was the largest region in the insulin infusion pump market in 2024